Ingar Holme

37.7k total citations · 10 hit papers
311 papers, 25.6k citations indexed

About

Ingar Holme is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ingar Holme has authored 311 papers receiving a total of 25.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Surgery, 77 papers in Cardiology and Cardiovascular Medicine and 66 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ingar Holme's work include Lipoproteins and Cardiovascular Health (68 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (45 papers) and Obesity, Physical Activity, Diet (32 papers). Ingar Holme is often cited by papers focused on Lipoproteins and Cardiovascular Health (68 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (45 papers) and Obesity, Physical Activity, Diet (32 papers). Ingar Holme collaborates with scholars based in Norway, Sweden and United States. Ingar Holme's co-authors include Roald Bahr, Ingvar Hjermann, Paul Leren, Sigmund A. Anderssen, Lars Engebretsen, Ingmar Jungner, Are H. Aastveit, Göran Walldius, Grethe Myklebust and Terje R. Pedersen and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ingar Holme

308 papers receiving 24.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

2012 1.5k citations Anders Olsson, Philip J. Barter et al. profile →
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

2008 1.1k citations Anne B. Rossebø, Terje R. Pedersen et al. profile →
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

2001 975 citations Göran Walldius, Ingmar Jungner et al. profile →
EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASE

1981 776 citations Ingvar Hjermann, Ingar Holme et al. profile →
Risk Factors for Injuries in Football

2004 678 citations Ingar Holme, Lars Engebretsen et al. profile →
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

2003 660 citations Hallvard Holdaas, Bengt Fellström et al. profile →
Comparison of Self-reported versus Accelerometer-Measured Physical Activity

2013 550 citations Ingar Holme, Sigmund A. Anderssen et al. profile →
Exercises to prevent lower limb injuries in youth sports: cluster randomised controlled trial

2005 518 citations Odd-Egil Olsen, Grethe Myklebust et al. BMJ profile →
Long-term risks for kidney donors

2013 496 citations Ingar Holme, Hallvard Holdaas et al. profile →
Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women

1999 491 citations Ingar Holme et al. BMJ profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ingar Holme	9.5k	6.8k	5.2k	4.7k	4.3k	311	25.6k
Erin D. Michos	5.9k 0.6×	11.7k 1.7×	5.4k 1.0×	1.2k 0.3×	4.7k 1.1×	689	30.5k
Vilmundur Guðnason	4.8k 0.5×	5.8k 0.8×	2.7k 0.5×	2.1k 0.4×	1.8k 0.4×	492	22.9k
Hans Wedel	14.7k 1.5×	21.7k 3.2×	15.0k 2.9×	2.6k 0.6×	2.6k 0.6×	268	44.2k
Matthew Allison	5.8k 0.6×	8.3k 1.2×	3.8k 0.7×	1.1k 0.2×	3.3k 0.8×	614	25.3k
Andrea Z. LaCroix	2.3k 0.2×	3.0k 0.4×	5.4k 1.0×	3.9k 0.8×	4.7k 1.1×	550	27.7k
Nanette K. Wenger	10.3k 1.1×	20.5k 3.0×	6.4k 1.2×	704 0.1×	2.9k 0.7×	372	35.9k
Lars Lind	3.2k 0.3×	9.1k 1.3×	3.9k 0.8×	757 0.2×	2.3k 0.5×	681	29.2k
Gary C. Curhan	6.5k 0.7×	4.0k 0.6×	4.3k 0.8×	842 0.2×	3.7k 0.9×	404	41.8k
Lars Wilhelmsen	8.9k 0.9×	12.6k 1.8×	8.1k 1.5×	461 0.1×	3.7k 0.9×	394	31.7k
Warren S. Browner	5.2k 0.5×	4.3k 0.6×	1.6k 0.3×	6.4k 1.4×	1.5k 0.3×	132	19.4k

Countries citing papers authored by Ingar Holme

Since Specialization

Citations

This map shows the geographic impact of Ingar Holme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingar Holme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingar Holme more than expected).

Fields of papers citing papers by Ingar Holme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingar Holme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingar Holme. The network helps show where Ingar Holme may publish in the future.

Co-authorship network of co-authors of Ingar Holme

This figure shows the co-authorship network connecting the top 25 collaborators of Ingar Holme. A scholar is included among the top collaborators of Ingar Holme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingar Holme. Ingar Holme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tikkanen, Matti J., Rana Fayyad, Rachel Laskey, et al.. (2011). Abstract 18079: Among CHD Patients in the IDEAL Study, Those with Elevated Levels of Alanine Aminotransferase at Baseline Had a Lower Rate of Major Coronary Events. Circulation. 124(suppl_21). 1 indexed citations

Jenum, Anne Karen, Kjersti Mørkrid, Line Sletner, et al.. (2011). Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. European Journal of Endocrinology. 166(2). 317–324. 193 indexed citations

Rossebø, Anne B., Christa Gohlke-Bärwolf, Kurt Boman, et al.. (2010). Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study). Lund University Publications (Lund University). 2 indexed citations

Tenga, Albin, Ingar Holme, Lars Tore Ronglan, & Roald Bahr. (2010). Effects of Match Location on Playing Tactics for Goal Scoring in Norwegian Professional Soccer. Journal of sport behavior. 33(1). 89. 14 indexed citations

Holme, Ingar, et al.. (2010). Can frozen and thawed blood samples stored for 12-14 years be used to measure levels of apolipoproteins? Analysis from HUNT 2 data.. Norsk Epidemiologi. 20(1). 125–130. 1 indexed citations

Holme, Ingar, Are H. Aastveit, Niklas Hammar, Ingmar Jungner, & Göran Walldius. (2009). Lipoprotein Components and Risk of Congestive Heart Failure in 84 740 Men and Women in the Apolipoprotein MOrtality RISk Study (AMORIS). European Journal of Heart Failure. 11(11). 1036–1042. 29 indexed citations

Holme, Ingar, Nilo B. Cater, Ole Færgeman, et al.. (2008). Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL). Annals of Medicine. 40(6). 456–464. 44 indexed citations

Steffen, Kathrin, Grethe Myklebust, Øystein E. Olsen, Ingar Holme, & Roald Bahr. (2008). Preventing injuries in female youth football – a cluster‐randomized controlled trial. Scandinavian Journal of Medicine and Science in Sports. 18(5). 605–614. 324 indexed citations

Håheim, Lise Lund, Ingar Holme, Anne Johanne Søgaard, & Per G. Lund‐Larsen. (2006). Endring i risikofaktorer for hjerte- og karsykdom blant menn i Oslo gjennom 28 år. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

10.

Kastelein, John J.P., Ingar Holme, Philip J. Barter, et al.. (2006). Abstract 3357: Superiority of ApoB/ApoA1 Ratio for Predicting Cardiovascular Risk in Pooled Analyses of the Incremental Decrease in Endpoints through Aggressive Lipid-Lowering (IDEAL) and Treating to New Targets (TNT) Trials. Circulation. 114. 2 indexed citations

11.

Olsen, Odd-Egil, Grethe Myklebust, Lars Engebretsen, Ingar Holme, & Roald Bahr. (2005). Exercises to prevent lower limb injuries in youth sports: cluster randomised controlled trial. BMJ. 330(7489). 449–449. 518 indexed citations breakdown →

12.

Holme, Ingar & Serena Tonstad. (2004). [Treatment with statins of the elderly].. PubMed. 124(2). 167–9. 1 indexed citations

13.

Holme, Ingar, Lise Lund Håheim, & Ingvar Hjermann. (2003). Prediksjonsfunksjoner for 21 års utvikling av hjerteinfarkt fra Oslo-undersøkelsen 1972/73. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

14.

Holdaas, Hallvard, Bengt Fellström, Ingar Holme, et al.. (2001). Effects of fluvastatin on cardiac events in renal transplant recipients. Journal of Cardiovascular Risk. 63–71. 1 indexed citations

15.

Otterstad, J. E., et al.. (1999). [Echocardiographic findings, pro-ANP and treatment in acute myocardial infarction without overt heart failure].. PubMed. 119(19). 2802–5. 2 indexed citations

16.

Sørensen, Merete Juul, et al.. (1999). The effect of exercise and diet on mental health and quality of life in middle-aged individuals with elevated risk factors for cardiovascular disease. Journal of Sports Sciences. 17(5). 369–377. 35 indexed citations

17.

Walldius, Göran, Uno Erikson, Anders Olsson, et al.. (1994). The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST). The American Journal of Cardiology. 74(9). 875–883. 180 indexed citations

18.

Walldius, Göran, Lars A. Carlson, Uno Erikson, et al.. (1988). Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report. The American Journal of Cardiology. 62(3). B37–B43. 48 indexed citations

19.

Helgeland, Anders, Ingvar Hjermann, Paul Leren, Sven Chr. Enger, & Ingar Holme. (1978). High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.. BMJ. 2(6134). 403–403. 114 indexed citations

20.

Holme, Ingar. (1976). [Mortality of Norwegian physicians in the period 1953-72 in relation to their smoking habits in 1952-3].. PubMed. 96(11). 620–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact